FORTRESS BIOTECHPRFA Valuation
| CNB0 Stock | EUR 6.35 0.85 11.81% |
At this time, the firm appears to be overvalued. FORTRESS BIOTECHPRFA shows a prevailing Real Value of €5.3 per share. The current price of the firm is €6.35. Our model computes the value of FORTRESS BIOTECHPRFA from evaluating the firm fundamentals such as Profit Margin of (1.17) %, return on asset of -0.35, and Shares Owned By Institutions of 1.80 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that FORTRESS BIOTECHPRFA's price fluctuation is unstable at this time. Calculation of the real value of FORTRESS BIOTECHPRFA is based on 3 months time horizon. Increasing FORTRESS BIOTECHPRFA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the FORTRESS stock is determined by what a typical buyer is willing to pay for full or partial control of FORTRESS BIOTECHPRFA 25. Since FORTRESS BIOTECHPRFA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of FORTRESS Stock. However, FORTRESS BIOTECHPRFA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.35 | Real 5.3 | Hype 6.35 |
The real value of FORTRESS Stock, also known as its intrinsic value, is the underlying worth of FORTRESS BIOTECHPRFA Company, which is reflected in its stock price. It is based on FORTRESS BIOTECHPRFA's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of FORTRESS BIOTECHPRFA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of FORTRESS BIOTECHPRFA 25 helps investors to forecast how FORTRESS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of FORTRESS BIOTECHPRFA more accurately as focusing exclusively on FORTRESS BIOTECHPRFA's fundamentals will not take into account other important factors: FORTRESS BIOTECHPRFA Total Value Analysis
FORTRESS BIOTECHPRFA 25 is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of 98.04 M, and cash on hands of 289.9 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the FORTRESS BIOTECHPRFA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 98.04 M | 289.9 M |
FORTRESS BIOTECHPRFA Investor Information
The company recorded a loss per share of 0.82. FORTRESS BIOTECHPRFA last dividend was issued on the 14th of February 2023. Based on the key measurements obtained from FORTRESS BIOTECHPRFA's financial statements, FORTRESS BIOTECHPRFA 25 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.FORTRESS BIOTECHPRFA Asset Utilization
One of the ways to look at asset utilization of FORTRESS is to check how much profit was generated for every dollar of assets it reports. FORTRESS BIOTECHPRFA 25 shows a negative utilization of assets of -0.35 percent, losing €0.003494 for each euro of assets held by the firm. Ineffective asset utilization denotes the company is being less competent with each euro of assets it shows. Put another way, asset utilization of FORTRESS BIOTECHPRFA 25 shows how unsuccessful it operates for each euro spent on its assets.FORTRESS BIOTECHPRFA Profitability Analysis
The company reported the revenue of 77.61 M. Net Loss for the year was (42.98 M) with loss before overhead, payroll, taxes, and interest of (85.66 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates FORTRESS BIOTECHPRFA's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in FORTRESS BIOTECHPRFA and how it compares across the competition.
About FORTRESS BIOTECHPRFA Valuation
The stock valuation mechanism determines FORTRESS BIOTECHPRFA's current worth on a weekly basis. Our valuation model uses a comparative analysis of FORTRESS BIOTECHPRFA. We calculate exposure to FORTRESS BIOTECHPRFA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of FORTRESS BIOTECHPRFA's related companies.Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.
8 Steps to conduct FORTRESS BIOTECHPRFA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates FORTRESS BIOTECHPRFA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct FORTRESS BIOTECHPRFA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain FORTRESS BIOTECHPRFA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine FORTRESS BIOTECHPRFA's revenue streams: Identify FORTRESS BIOTECHPRFA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research FORTRESS BIOTECHPRFA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish FORTRESS BIOTECHPRFA's growth potential: Evaluate FORTRESS BIOTECHPRFA's management, business model, and growth potential.
- Determine FORTRESS BIOTECHPRFA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate FORTRESS BIOTECHPRFA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for FORTRESS Stock analysis
When running FORTRESS BIOTECHPRFA's price analysis, check to measure FORTRESS BIOTECHPRFA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FORTRESS BIOTECHPRFA is operating at the current time. Most of FORTRESS BIOTECHPRFA's value examination focuses on studying past and present price action to predict the probability of FORTRESS BIOTECHPRFA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FORTRESS BIOTECHPRFA's price. Additionally, you may evaluate how the addition of FORTRESS BIOTECHPRFA to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |